eeshrita

🧫🧬

[eeshrita @eeshrita]

@Chaudhary9Nazia @biopatrika Thank you for the support!

[eeshrita @eeshrita]

Thank you for featuring our work! @Chaudhary9Nazia @ACTREC_TMC

Looking for a simple explanation of what we did? Read it here 🧫⬇️

[Biopatrika @biopatrika]

#authorinterview @eeshrita from lab of @Chaudhary9Nazia @ACTREC_TMC talks about her work on "Targeting lipid metabolism to overcome therapy resistance in Colorectal Cancer!" https://t.co/2UgHcXENQM via @biopatrika

[Nazia Chaudhary @Chaudhary9Nazia]

I'm delighted to share an author interview of my Research Assistant, Eeshrita Jog @eeshrita in Biopatrika @biopatrika.
Thanks, Biopatrika for featuring Eeshrita and her exciting study on Targeting lipid metabolism to overcome therapy resistance in CRC.
Read her interview here.

[eeshrita @eeshrita]

@Chaudhary9Nazia 🥳

[Nazia Chaudhary @Chaudhary9Nazia]

I'm thrilled to announce that the second part of my DST inspire project has been published in the prestigious CCR journal !

Patient-derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas https://t.co/lemBtALc9T

[eeshrita @eeshrita]

@Chaudhary9Nazia Congratulations! ❤️

[eeshrita @eeshrita]

I’m grateful to @Chaudhary9Nazia for the opportunity and for being an amazing mentor. We’ve spent a lot of time together in the lab discussing and working towards this paper- and I can’t wait to read all the groundbreaking work she’s going to come out with over the years ❤️

[eeshrita @eeshrita]

Happy to announce that my first-author paper with Dr. Chaudhary is finally published! 🎉 This is paper is the result of working with so many amazing people—thank you all for your contributions and support along the way.

[Nazia Chaudhary @Chaudhary9Nazia]

I'm thrilled to announce that my paper in redox biology is finally out! This milestone marks my first solo corresponding author publication, a significant achievement i'm proud to share. Seeing the final product is surreal, and I'm grateful to share this moment with you. (1/6)

[eeshrita @eeshrita]

@Chaudhary9Nazia Congratulations, Dr. Chaudhary! ❤️ Thank you for the opportunity and your guidance throughout this journey. It has been amazing to learn from, and work with you, and I’m so excited to see the remarkable heights you’ll reach in the future!

[eeshrita @eeshrita]

@Chaudhary9Nazia @IACR2024 Wow! Happy to see that you finally met Dr. Ateeq after talking about her work for so long! 💓

[eeshrita @eeshrita]

@DrVermaNandini @biorxivpreprint @TnbcL Congratulations 🎉

[Nandini Verma @DrVermaNandini]

n/1 That's an absolute delight for @TnbcL to share our first pre-print at @biorxivpreprint that undermines converged targetable vulnerabilities of Proliferating Drug-Tolerant Persister (PDTP) cells derived from 4 subtypes of Triple-Negative Breast Cancer🎯https://t.co/XjPpxg4cNT

[bioRxiv @biorxivpreprint]

GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition. https://t.co/ZhHsTDyJg9 #bioRxiv

[eeshrita @eeshrita]

Delighted to share that our pre-print exploring the therapeutic vulnerabilities of PDTP’s in TNBC subtypes is now available on @biorxivpreprint! Congratulations to the whole team 🎉

[bioRxiv @biorxivpreprint]

GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition. https://t.co/ZhHsTDyJg9 #bioRxiv